Alpha Biologics Overview
- Year Founded
-
2003
- Status
-
Acquired/Merged
- Employees
-
11
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$21M
Alpha Biologics General Information
Description
Manufacturer of biologic drugs for use in preclinical, Phase1 and 2 clinical trials. The company specialises in the production of mammalian cell secreted protein drugs.
Contact Information
Primary Industry
Drug Discovery
Acquirer
Primary Office
- Plot 302, Taman Perindustrian Bukit Minyak
- Seberang Perai Tengah
- Penang, 14100
- Malaysia
Alpha Biologics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 22-Feb-2011 | $21M | 000 | 0000 | Completed | Generating Revenue |
| 1. Early Stage VC | 20-Nov-2006 | 000 | 000 | Completed | Generating Revenue |
Alpha Biologics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Alpha Biologics Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Asiaprise Biotech | Corporation | Minority | 000 0000 | 000000 0 | |
| Pequot Capital Management | Hedge Fund | Minority | 000 0000 | 000000 0 | |
| SpringHill Management | Asset Manager | Minority | 000 0000 | 000000 0 |
Alpha Biologics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CTM Biotech | 05-Jan-2007 | 0000000000 | Laboratory Services (Healthcare) | 00000 000 |